Compositions and methods for delivery of genetic material
    41.
    发明授权
    Compositions and methods for delivery of genetic material 失效
    用于遗传物质传递的组合物和方法

    公开(公告)号:US5981505A

    公开(公告)日:1999-11-09

    申请号:US979385

    申请日:1997-11-26

    摘要: Methods of inducing genetic material into cells of an individual and compositions and kits for practicing the same are disclosed. The methods comprise the steps of contacting cells of an individual with a polynucleotide function enhancer and administering to the cells, a nucleic acid molecule that is free of retroviral particles. The nucleic acid molecule comprises a nucleotide sequence that encodes a protein that comprises at least one epitope that is identical or substantially similar to an epitope of a pathogen antigen or an antigen associated with a hyperproliferative or autoimmune disease, a protein otherwise missing from the individual due to a missing, non-functional or partially functioning gene, or a protein that produces a therapeutic effect on an individual. Methods of prophylactically and therapeutically immunizing an individual against HIV are disclosed. Pharmaceutical compositions and kits for practicing methods of the present invention are disclosed.

    摘要翻译: PCT No.PCT / US94 / 00899 Sec。 371日期:1995年8月28日 102(e)日期1995年8月28日PCT 1994年1月26日PCT PCT。 公开号WO94 / 16737 日期1994年8月4日公开了将遗传物质诱导入个体细胞的方法和用于实施其的组合物和试剂盒。 所述方法包括使个体的细胞与多核苷酸功能增强子接触并向细胞施用不含逆转录病毒颗粒的核酸分子的步骤。 核酸分子包含编码蛋白质的核苷酸序列,该蛋白质包含与病原体抗原或与过度增殖或自身免疫疾病相关的抗原的表位相同或基本相似的至少一个表位, 涉及缺失的,非功能的或部分功能的基因或对个体产生治疗作用的蛋白质。 公开了预防和治疗个体免受HIV感染的方法。 公开了用于本发明的实践方法的药物组合物和试剂盒。

    VACCINES FOR SUPPRESSING IGE-MEDIATED ALLERGIC DISEASE AND METHODS FOR USING THE SAME
    48.
    发明申请
    VACCINES FOR SUPPRESSING IGE-MEDIATED ALLERGIC DISEASE AND METHODS FOR USING THE SAME 审中-公开
    用于抑制神经介导的过敏性疾病的疫苗及其使用方法

    公开(公告)号:US20140127244A1

    公开(公告)日:2014-05-08

    申请号:US14054621

    申请日:2013-10-15

    IPC分类号: A61K39/00 A61K39/08

    摘要: Nucleic acid molecules that encode a protein comprising at least one epitope of membrane IgE free of epitopes present on the serum IgE, including proteins that further comprise non-IgE T cell helper epitope are disclosed. Vaccines, vectors and host cells that comprise such nucleic acid molecules are disclosed. Isolated proteins, including haptenized proteins, comprising at least one epitope of membrane IgE free of epitopes present on the serum IgE, including proteins that further comprise non-IgE T cell helper epitope are disclosed. Vaccines that comprise and methods of making such proteins and antibodies that specifically bind to such proteins are disclosed. Vaccines that comprise killed or inactivated cells or particles are disclosed. Methods of treating and preventing IgE mediated allergic disease or condition are disclosed.

    摘要翻译: 公开了编码蛋白质的核酸分子,其包含不含存在于血清IgE上的表位的膜IgE的至少一个表位,包括进一步包含非IgE T细胞辅助表位的蛋白质。 公开了包含这种核酸分子的疫苗,载体和宿主细胞。 公开了分离的蛋白质,包括半抗原蛋白,其包含至少一个不含存在于血清IgE上的表位的膜IgE表位,包括进一步包含非IgE T细胞辅助表位的蛋白质。 公开了包含制备这种蛋白质和特异性结合这些蛋白质的抗体的方法的疫苗。 公开了包含杀死或灭活的细胞或颗粒的疫苗。 公开了治疗和预防IgE介导的过敏性疾病或病症的方法。